Compliance updated on Sep 10, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Delivra Health Brands Inc

DHB.V ✗ NOT COMPLIANTFree checks used up today ☆ Track — members

TSX · Healthcare · Pharmaceuticals ·

Canada Micro Cap Analyst: BUY

Last Close

$0.05

▼ -6.25%

Market Cap $1.68M · Vol 39.35K

Price charts are for members

Interactive price history from intraday to 5 years, on every stock and ETF.

See plans

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$1.68M

Micro Cap

Div Yield

N/A

EPS Growth

N/A

YoY

RSI (14)

40.00

Momentum

Beta

0.93

vs Market

52W High

$0.25

78.48% below

52W Low

$0.05

9.18% above

Volume

39.35K

Avg 20.86K

P/B

N/A

Price-to-book

ROE

N/A

Return on equity

Free Float

86.10%

Public shares

Shariah Compliance8 STANDARDS

✗ Delivra Health Brands Inc (DHB.V) stock is currently not Shariah compliant

You’ve used your 10 free compliance checks today

Choose a plan

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See which standards it fails, the exact ratios behind the verdict, and halal alternatives.Members see the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does DHB.V pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-21.05%

-11.76%

-25.00%

-50.00%

YTD

-63.41%

-72.22%

-50.41%

-89.29%

Financials & Valuation

TTM · Annual

Total Revenue	$6.08M
Net Income	N/A
Revenue Growth (YoY)	-60.03%
Gross Margin	39.00%
Operating Margin	-23.19%
Net Profit Margin	-26.12%
ROE	N/A
ROA · ROIC	N/A · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	0.36
P/B	N/A
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	31.26M

Technical Indicators

50-Day SMA	$0.07
200-Day SMA	$0.09
RSI (14)	40.00
Beta	0.93
52-Week High	$0.25
52-Week Low	$0.05

Volume Today	39.35K
Avg Daily Volume (30D)	20.86K
Relative Volume	1.89x
Volatility (10D)	60.46
Volatility (30D)	113.02
Free Float	86.10%

Analyst Consensus

BUY

Current Price $0.05

Mean Target $0.38

52W Low$0.05 52W High$0.25

Current

Target

$0.05 $0.25

Current Analyst target

+606.36% upside potential · 0 analysts

Identifiers

ExchangeTSX

FIGIBBG001T62SQ0

ISINCA24703H2019

CountryCanada

Sub-IndustryRecreational Pharmaceuticals

Earnings DateNov 21, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

LLY Eli Lilly and Company +3.19% JNJ Johnson & Johnson -0.73% ABBV AbbVie Inc. +1.41% MRK Merck & Co Inc +2.18% NVS Novartis AG -0.19%

Company Profile

Delivra Health Brands Inc. is a Canada-based consumer packaged goods company. The Company provides products that help with pain, sleep, anxiety, and performance through its brands LivRelief and Dream Water. It operates a portfolio of brands under its Consumer Division consisting of Dream Products Inc. and Delivra Corp. Dream Water provides non-habit-forming sleep solutions in formats to suit various consumer needs. It features its proprietary SleepStat blend, a combination of melatonin, gamma-aminobutyric acid, and 5-hydroxytryptophan. Its product range includes 74ml (2.5oz) liquid sleep shots, gummies, and powder. Delivra Corp. manufactures and sells a growing line of topical creams with the proprietary transdermal delivery system platform under the LivRelief brand for conditions, such as joint and muscle pain, nerve pain, varicose veins, and wound healing creams. LivRelief Infused launched cannabidol and tetrahydrocannabinol-infused topical formulations through licensing agreements.